Data science is shaping our discovery and development efforts
We are using advanced data science and neuroinformatics to map drug targets to specific brain circuitry and corresponding behaviors.
Stay informed about our latest developments
- September 9, 2019 BlackThorn Therapeutics Appoints Healthcare Technology Innovator, Monique Levy, as Chief Strategy Officer
- July 22, 2019 BlackThorn Therapeutics Announces Its Participation in the Reward Task Optimization Consortium (RTOC)
- June 13, 2019 BlackThorn Therapeutics Closes $76 Million Series B to Advance Targeted Therapeutics for Mental Health